CEimpact Podcast

Allergic reactions can range from a bothersome nuisance to a life-threatening emergency, making it crucial for pharmacists to stay informed about current treatment options and best practices. This episode discusses common triggers, effective therapies—from antihistamines and injections to the newly approved epinephrine nasal spray—and key counseling strategies to ensure patients receive safe, prompt relief. Tune in to improve your preparedness and support confident, patient-centered care.

HOST
Joshua Davis Kinsey, PharmD
VP, Education
CEimpact

Rachel Maynard, PharmD
Lead Editor
Pyrls

Joshua Davis Kinsey and Rachel Maynard have no relevant financial relationships to disclose. 

CPE REDEMPTION
This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation:

• If you are already enrolled in this course, click here to redeem your credit. 
• To purchase this episode and claim your CPE credit, click here. 

CPE INFORMATION
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Identify common triggers and clinical features associated with allergic reactions.
2. Describe available treatment options for allergic reactions, including newly approved therapies and their appropriate use.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-300-H01-P
Initial release date: 10/6/2025
Expiration date: 10/6/2026
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

With numerous new medications launching each year, pharmacists play a vital role in translating complex drug information into practical, patient-centered care. This episode offers a brief overview of select FDA-approved drugs from the past year, highlighting their therapeutic importance, key considerations, and clinical uses. Whether counseling patients or working with healthcare providers, pharmacists need to stay informed about what’s new—and understand its impact on practice.

HOST
Joshua Davis Kinsey, PharmD
VP, Education
CEimpact

GUEST
Joe Strain, PharmD
Professor of Pharmacy Practice
South Dakota State University/Monument Health Rapid City Hospital

Joshua Davis Kinsey and Joe Strain have no relevant financial relationships to disclose. 

CPE REDEMPTION
This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation:

• If you are already enrolled in this course, click here to redeem your credit. 
• To purchase this episode and claim your CPE credit, click here. 

CPE INFORMATION
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. List unique pharmacological properties for select newly approved medications.
2. Recognize important safety considerations, including adverse effects, interactions, and monitoring parameters, for each featured drug.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-295-H01-P
Initial release date: 9/29/2025
Expiration date: 9/29/2026
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

The FDA remains a powerful driver of change in pharmacy practice through its approvals, policies, and public health actions. This episode highlights timely FDA developments and emerging areas of focus that pharmacists need to be aware of—from regulatory shifts to new communication initiatives. Tune in to stay informed on FDA activity that could influence the way you practice and care for patients.

HOST
Joshua Davis Kinsey, PharmD
VP, Education
CEimpact

GUEST
Mary Ross Southworth, PharmD
Principal
S&S Consulting Partners

Joshua Davis Kinsey has no relevant financial relationships to disclose.
Mary Ross Southworth is a consultant for Travere, Unicycive, Liquidia, and Mineralys. All relevant financial relationships have been mitigated. 


CPE REDEMPTION
This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation:

• If you are already enrolled in this course, click here to redeem your credit. 
• To purchase this episode and claim your CPE credit, click here. 

CPE INFORMATION
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Recognize current FDA topics and areas of focus relevant to pharmacy practice.
2. Describe how current FDA priorities may impact medication use, pharmacist responsibilities, or patient care.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-296-H03-P
Initial release date: 9/22/2025
Expiration date: 9/22/2026
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

As more patients live beyond cancer treatment, survivorship care is becoming an essential—but often overlooked—part of the healthcare journey. This episode explores how pharmacists can support survivors through medication management, mental health awareness, lifestyle counseling, and connection to broader care resources. Tune in to learn how you can play a meaningful role in helping patients navigate life after cancer.

HOST
Joshua Davis Kinsey, PharmD
VP, Education
CEimpact

GUEST
Erica Marchese, PharmD, BCPS, BCOP, BCSCP, MHA
Clinical Pharmacy Program Director
City of Hope

Joshua Davis Kinsey and Erica Marchese have no relevant financial relationships to disclose.


CPE REDEMPTION
This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation:

• If you are already enrolled in this course, click here to redeem your credit. 
• To purchase this episode and claim your CPE credit, click here. 

CPE INFORMATION
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Identify common physical, emotional, and medication-related challenges faced by patients in the survivorship phase of cancer care.
2. Describe the pharmacist's role in supporting survivorship through medication review, lifestyle counseling, and care coordination.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-292-H01-P
Initial release date: 9/15/2025
Expiration date: 9/15/2028
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Falls are a leading cause of injury and death in older adults, and pharmacists are in a key position to help prevent them. This episode highlights how to identify medication risks, share practical prevention strategies, and connect patients with trusted tools and resources. Tune in to learn how you can make a meaningful impact in reducing falls in your community. 

HOST
Joshua Davis Kinsey, PharmD
VP, Education
CEimpact

GUEST
Kristin Meyer PharmD, BCGP, FASCP
Professor of Pharmacy Practice
Drake University College of Pharmacy and Health Sciences

Joshua Davis Kinsey and Kristin Meyer have no relevant financial relationships to disclose. 

RESOURCES

• National Council on Aging (NCOA) Falls Prevention
• NCOA Falls Prevention Awareness Week
• NCOA Falls Free CheckUp®
• CDC STEADI

CPE REDEMPTION
This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation:

• If you are already enrolled in this course, click here to redeem your credit. 
• To purchase this episode and claim your CPE credit, click here.

CPE INFORMATION
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Identify common medication classes and household hazards associated with increased fall risk in older adults.
2. Describe the pharmacist's role in fall prevention through medication review, patient education, and community engagement.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-269-H05-P
Initial release date: 9/8/2025
Expiration date: 9/8/2028
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

With shifting policies, payment models, and an unpredictable respiratory virus landscape,  pharmacy teams need more than clinical updates to prepare for the upcoming immunization season. This episode explores key issues shaping immunization practice today — including policy changes, billing and documentation trends, and how teams can proactively adapt and advocate for their role. Tune in for timely insights that go beyond the clinical headlines and complement our in-depth, on-demand course, Annual Immunization Update 2025. 

HOST
Joshua Davis Kinsey, PharmD
VP, Education
CEimpact

GUEST
Elizabeth Skoy, PharmD
Professor
North Dakota State University 

Joshua Davis Kinsey and Elizabeth Skoy have no relevant financial relationships to disclose.
 

CPE REDEMPTION
This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation:

• If you are already enrolled in this course, click here to redeem your credit. 
• To purchase this episode and claim your CPE credit, click here. 

CPE INFORMATION
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Recognize recent policy and reimbursement updates that influence pharmacy-based immunization services and their potential to improve patient access to care.
2. Identify strategies pharmacy teams can use to prepare for the 2025-26 respiratory virus season in ways that support timely, equitable, and effective patient immunization.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-286-H01-P
Initial release date: 9/1/2025
Expiration date: 9/1/2026
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Low-dose naltrexone (LDN) is generating growing interest as a potential therapy for conditions such as chronic pain and immune-related disorders. This episode offers a foundational overview of what LDN is, how it’s thought to work, where current evidence stands, and how pharmacists may encounter it in practice. Learn what pharmacists need to know to confidently approach patient questions about LDN and how it fits into current conversations in pharmacy and patient care.

HOST
Joshua Davis Kinsey, PharmD
VP, Education
CEimpact

GUEST
Michelle Moser, RPh
Retired Compounding Pharmacist

Joshua Davis Kinsey has no relevant financial relationships to disclose.

Michelle Moser was a volunteer board member for LDN Research Trust (ended June 2025), a board member for Alliance for Pharmacy Compounding (ended September 2024), and an employee of Revelation Pharma (ended June 2024). All relevant financial relationships have been mitigated.   


CPE REDEMPTION
This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation:

• If you are already enrolled in this course, click here to redeem your credit. 
• To purchase this episode and claim your CPE credit, click here. 

CPE INFORMATION
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Define low-dose naltrexone (LDN) and describe how it differs from traditional naltrexone dosing.   
2. Identify proposed mechanisms of action and areas of emerging interest related to LDN use in practice.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-275-H01-P
Initial release date: 8/25/2025
Expiration date: 8/25/2026
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Compounded medications serve a critical role in meeting patient-specific needs, but compliance is essential to ensure safety and quality. This episode covers what pharmacists need to know about documentation, prescription validity, beyond-use dating, and common missteps that can put compliance at risk. Tune in to strengthen your compounding practices and stay aligned with current regulatory expectations.

HOST
Joshua Davis Kinsey, PharmD
VP, Education
CEimpact

Jessica Gustin, PharmD
CMO & PIC/COO
Gwinnett Drugs/SynerGrx

Joshua Davis Kinsey and Jessica Gustin have no relevant financial relationships to disclose.
 
CPE REDEMPTION
This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation:

• If you are already enrolled in this course, click here to redeem your credit. 
• To purchase this episode and claim your CPE credit, click here. 

CPE INFORMATION
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Identify key compliance requirements related to patient-specific prescriptions and compounded medication preparation.
2. Describe common compliance challenges in pharmacy compounding and strategies to avoid regulatory missteps.

0.05 CEU/0.5 Hr
UAN:  0107-0000-25-273-H07-P
Initial release date: August 18, 2025
Expiration date: August 18, 2026
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Uncontrolled hypertension continues to drive cardiovascular risk and remains a major gap in chronic disease management. This episode discusses what pharmacists need to know to support treatment adherence, identify therapeutic gaps, and address barriers to blood pressure control. Listen to strengthen your role in helping patients achieve meaningful, sustained outcomes. 

HOST
Joshua Davis Kinsey, PharmD
VP, Education
CEimpact

GUEST
Ryan Jacobsen, PharmD, BCPS
Clinical Pharmacy Specialist
U of Iowa HealthCare

Joshua Davis Kinsey and Ryan Jacobsen have no relevant financial relationships to disclose. 

CPE REDEMPTION
This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation:

• If you are already enrolled in this course, click here to redeem your credit. 
• To purchase this episode and claim your CPE credit, click here. 

CPE INFORMATION
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Identify common causes and consequences of uncontrolled hypertension in various patient populations.
2. Describe the pharmacist's role in recognizing gaps in therapy, addressing adherence, and supporting blood pressure control.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-271-H01-P
Initial release date: 8/11/2025
Expiration date: 8/11/2028
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

With sexually transmitted infection (STI) rates continuing to rise, over-the-counter testing kits are expanding access to care, and pharmacists are well-positioned to support their safe and effective use. This episode explores key facts about available OTC kits, regulatory updates, counseling responsibilities, and the potential for test-and-treat models in pharmacy practice. Join us to learn how pharmacists can contribute meaningfully to STI prevention and care.

HOST
Joshua Davis Kinsey, PharmD
VP, Education
CEimpact

GUEST
Elizabeth Skoy, PharmD
Professor
North Dakota State University

Joshua Davis Kinsey and Elizabeth Skoy have no relevant financial relationships to disclose.
 

CPE REDEMPTION
This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation:

• If you are already enrolled in this course, click here to redeem your credit. 
• To purchase this episode and claim your CPE credit, click here. 

CPE INFORMATION
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Identify the types and regulatory status of over-the-counter STI testing kits available to patients.
2. Describe the pharmacist's role in educating patients on the use of OTC STI kits and recognizing potential opportunities to support follow-up care or treatment.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-270-H01-P
Initial release date: 8/4/2025
Expiration date: 8/4/2026
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram